文献速递内脏/肾动脉与血管畸形

内脏动脉瘤开放修复术的围手术期并发症与死亡风险

Morbidity and mortality associated with open repair of visceral aneurysms.
PubMed 文献 · J Vasc Surg · 2021-09-22

基于2013至2019年NSQIP数据库,304例接受开放修复的内脏动脉瘤中,263例未破裂者30天死亡率为1.9%、主要并发症率为12.9%,破裂者死亡率22.0%、并发症率34.1%;男性、出血风险及低白蛋白是非破裂动脉瘤不良结局的预测因素。

要点

  • 未破裂内脏动脉瘤开放修复的30天死亡率为1.9%,主要并发症率为12.9%。
  • 破裂后死亡率和主要并发症率分别升至22.0%和34.1%。
  • 男性、抗凝或出血性疾病、白蛋白<3.0 g/dL是非破裂动脉瘤不良结局的预测因素。

核心结论

  • 开放修复内脏动脉瘤的并发症与死亡率可接受,但一旦破裂则风险显著增加。
  • 男性、出血风险及低白蛋白是不良事件的危险因素,应纳入手术规划和术后管理。

研究设计与样本

  • 回顾性队列研究,查询2013至2019年NSQIP数据库。
  • 共纳入304例接受开放修复的内脏动脉瘤患者,其中未破裂263例(肠系膜137、肾66、脾60),破裂41例(肠系膜24、肾1、脾16)。
  • 主要终点为主要并发症(心血管、肺部、进行性肾衰竭、深部伤口感染、重返手术室、脓毒症)与30天死亡率的复合终点。
  • 采用逻辑回归识别非破裂动脉瘤主要终点的预测因素。

主要发现

  • 非破裂动脉瘤患者平均年龄59.4±14.7岁,女性占48.3%。
  • 非破裂动脉瘤30天死亡率为1.9%,主要并发症率为12.9%;重返手术室(5.3%)和延长呼吸机支持(3.8%)较常见。
  • 破裂者死亡率显著更高(22.0%;P < .001),主要并发症率也更高(34.1%;P = .001)。
  • 术后输血在择期组常见,但破裂组显著更高(24.3% vs 80.5%;P < .001)。
  • 非破裂动脉瘤主要终点的预测因素包括男性(OR 2.93;95%CI 1.28-6.7;P = .011)、抗凝未术前停药或出血性疾病(OR 4.52;95%CI 1.37-14.7;P = .012)、白蛋白<3.0 g/dL(OR 4.66;95%CI 1.17-18.6;P = .029);年龄和动脉瘤位置均非显著危险因素。

关键数值与推荐

  • 非破裂内脏动脉瘤开放修复:30天死亡率1.9%,主要并发症率12.9%。
  • 破裂内脏动脉瘤开放修复:30天死亡率22.0%,主要并发症率34.1%。
  • 非破裂动脉瘤不良结局预测因素:男性OR 2.93(95%CI 1.28-6.7;P = .011);抗凝未停药或出血性疾病OR 4.52(95%CI 1.37-14.7;P = .012);白蛋白<3.0 g/dL OR 4.66(95%CI 1.17-18.6;P = .029)。

临床怎么用

  • 对于内脏动脉瘤开放修复,应充分评估破裂风险以决定手术时机,破裂后风险显著升高。
  • 术前应关注男性、抗凝或出血性疾病、低白蛋白等危险因素,优化围手术期管理。
  • 术后需警惕重返手术室和延长呼吸机支持等常见并发症。

局限性

  • 研究为回顾性数据库分析,可能存在编码偏倚和未测量混杂因素。
  • 样本量有限(共304例),部分亚组例数较少。
  • 仅纳入开放修复病例,未比较腔内修复或其他治疗方式。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Society for Vascular Surgery (SVS) recently published clinical practice guidelines on the management of visceral aneurysms. However, studies investigating the perioperative outcomes of open repair of visceral aneurysms have been limited to single-center experiences with variable results that span multiple decades. In the present study, we sought to detail the morbidity and mortality associated with open repair of visceral aneurysms using a national database in the contemporary era. METHODS: National Surgical Quality Improvement Program data from 2013 to 2019 were queried for patients who had undergone open repair of visceral aneurysms, which had been classified as mesenteric, renal, or splenic using Current Procedural Terminology and International Classification of Diseases codes. The primary endpoint was the composite of major complications (cardiovascular, pulmonary, progressive renal failure, deep wound infection, return to operating room, sepsis) and 30-day mortality. Logistic regression was used to identify the predictors of the primary endpoint for nonruptured aneurysm cases. RESULTS: Of the 304 aneurysms, 263 were nonruptured (137 mesenteric, 66 renal, 60 splenic) and 41 were ruptured (24 mesenteric, 1 renal, 16 splenic) and had undergone open repair. For those with nonruptured aneurysms, their mean age was 59.4 ± 14.7 years and 48.3% were women. For those with nonruptured aneurysms, the 30-day mortality was 1.9% and the major complication rate was 12.9%. A return to the operating room (5.3%) and prolonged ventilator support (3.8%) were especially common. As expected, rupture was associated with significantly greater mortality (22.0%; P < .001) and major complications (34.1%; P = .001). The use of postoperative transfusion was common in the elective group but was significantly greater in the ruptured group (24.3% vs 80.5%; P < .001). The predictors of the primary outcome for nonruptured aneurysms included male sex (odds ratio [OR], 2.93; 95% confidence interval [CI], 1.28-6.7; P = .011), anticoagulation (not discontinued before surgery) or bleeding disorder (OR, 4.52; 95% CI, 1.37-14.7; P = .012), and albumin <3.0 g/dL (OR, 4.66; 95% CI, 1.17-18.6; P = .029). Neither age nor aneurysm location were significant risk factors. CONCLUSIONS: Open repair of visceral aneurysms was associated with acceptable morbidity and mortality, although these risks are significantly greater once ruptured. Male sex, bleeding risk, and low albumin were all risk factors for adverse events and should be considered for operative planning and postoperative care.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. DeCarlo C, Mohebali J, Dua A, et al. Morbidity and mortality associated with open repair of visceral aneurysms. J Vasc Surg. 2021. PMID: 34560216. doi:10.1016/j.jvs.2021.08.079

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。